Medical

New Australian evidence to support lowering bowel cancer screening age

Health Industry Hub | June 29, 2020 |
[Total: 1    Average: 5/5]

Medical News: A new Australian study has found the rates of bowel cancer in people under 50 continue to rise, supporting Bowel Cancer Australia’s Never2Young campaign to lower the screening age from 50 to 45.

Published in the ANZ Journal of Surgery in June 2020, the Gold Coast study found growing evidence of increasing rates of bowel cancer in people under age 50 after reviewing 557 patients who received a colonoscopy between 2013 and 2017.

The study noted bowel cancer was estimated to be the leading cause of cancer death in young males (30–34 years) and females (25-34 years) in 2019, which led the authors to question if current screening guidelines (50-74) may need to be reconsidered and introduced to younger populations.

Colorectal surgeon and Bowel Cancer Australia Director, Associate Professor Graham Newstead AM said “A lower start-age for bowel cancer screening could be part of the solution, along with improved symptom awareness among both patients and GPs.”

“Over 1,500 bowel cancer cases occur in people under age 50 each year, so we need to be bold and begin screening those between 45-49 while also increasing screening participation rates for those over 50,” he said.

The study found 21.5% of colonoscopies performed on patients under 50 identified pathology (adenomas); and 1.9% were diagnosed with bowel cancer. All patients diagnosed with bowel cancer experienced symptoms, having stage 3 (36.4%) or 4 (45.5%) cancer at diagnosis.

Dannielle Bower was diagnosed with bowel cancer at the age of 28. Over a period of a few years she sought medical help and knew something wasn’t quite right, but bowel cancer was constantly dismissed because of her age. This delay resulted in her stage 4 diagnosis.

“My age was not a factor. You’re never too young to get bowel cancer as it can strike anyone at any time,” Dannielle said.

“I was 28, in the prime of my life when diagnosed with bowel cancer,” she added.

Selfcare In Healthcare Coalition on Mental Health Support in Pharma, Biotech and MedTech

“I urge everyone, especially younger people, to know the signs and symptoms of bowel cancer. If something doesn’t feel right, it’s important to speak up,” Dannielle said.

These findings correlate with published research in the Lancet Gastroenterology & Hepatology (May 2019), that found the number of people under age 50 diagnosed with colon (2.9%) and rectal cancer (2.6%) increasing significantly each year in Australia.

In May 2018, the American Cancer Society revised its screening age guidelines down from 50 to 45 due to increasing rates among younger people.

Bowel cancer is Australia’s second deadliest cancer. 108 people die every week from the disease.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Private health insurer looking to invest in Australian private hospitals

Private health insurer looking to invest in Australian private hospitals

Health Industry Hub | July 15, 2020 |

MedTech News: In a recent opinion piece Dr Bill Coote, former AMA Secretary General and former Director of the Medicare […]

More


News & Trends - Pharmaceuticals

Pharma News - Merck Australia supports the first Australian-developed COVID-19 vaccine - Sypharma and Vaxine

Merck Australia supports the first Australian-developed COVID-19 vaccine

Health Industry Hub | July 15, 2020 |

Pharma News: Sypharma, an Australian biopharmaceutical formulation company, announced manufacturing of COVAX-19 and Advax adjuvant for Covid-19 in partnership with […]

More


News & Trends - Pharmaceuticals

Pharma News - Precision prescribing to combat Australia’s expected surge in mental illness

Precision prescribing to combat Australia’s expected surge in mental illness

Health Industry Hub | July 15, 2020 |

Pharma News: COVID-19 social isolation, familial and community disconnection, shock, job loss and health fears create the perfect storm for […]

More


Medical

Medical Pharma Biotech MedTech - $47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

$47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

Health Industry Hub | July 15, 2020 |

Medical News: The operation of the Australian Government’s $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular […]

More